In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae
Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM...
Gespeichert in:
Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 1996-09, Vol.40 (9), p.2062-2066 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2066 |
---|---|
container_issue | 9 |
container_start_page | 2062 |
container_title | Antimicrobial Agents and Chemotherapy |
container_volume | 40 |
creator | CHAVANET, P PEYRARD, N PECHINOT, A BUISSON, M DUONG, M NEUWIRTH, C KAZMIERCZAK, A PORTIER, H |
description | Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
doi_str_mv | 10.1128/aac.40.9.2062 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_163473</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15697498</sourcerecordid><originalsourceid>FETCH-LOGICAL-a526t-758261c34637f9141a0f8e52e00f3c0c2db7972ea76a2a15123f159a366d3e353</originalsourceid><addsrcrecordid>eNqFkkuLFDEUhQtRxnF06VKIIC6EavOoJJWFi6bxMTDgQl2H26lkOkNVUiapHvsP-TutpppmXIgQCJfz3XPzOFX1kuAVIbR9D2BWDV6pFcWCPqouCVZtLbgSj6tLjIWomxY3T6tnOd_hueYKX1QXbStb3pLL6vd1QHu_jwhM8XtfDghCh8YdpAFM7A4BBm8yig7BEH954_veBzQvE4etD1B8DOjelx1yMbs4HMwiO79NR6qPJc-1s6bYbgF3_nbXH9Bow8muTjb7XCAU9K0kO5ZoojFTRmOw0xCDB_u8euKgz_bFab-qfnz6-H3zpb75-vl6s76pgVNRaslbKohhjWDSKdIQwK61nFqMHTPY0G4rlaQWpAAKhBPKHOEKmBAds4yzq-rD4jtO28F2xoaSoNdj8gOkg47g9d9K8Dt9G_eaCNZINve_PfWn-HOyuejBZ2P7HoKNU9aybbiiTP0XJFwo2ah2BusFNCnmnKw7H4ZgfQyAXq83usFa6WMAZv7dwkMeqL6LUwrzg_0TfvXwumfrUzxm_c1Jh2ygdwmC8fmMMYqlxHLGXi_Y8WvvfbJ6Hq7nYD4Y9QdfqtYI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15697498</pqid></control><display><type>article</type><title>In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>CHAVANET, P ; PEYRARD, N ; PECHINOT, A ; BUISSON, M ; DUONG, M ; NEUWIRTH, C ; KAZMIERCZAK, A ; PORTIER, H</creator><creatorcontrib>CHAVANET, P ; PEYRARD, N ; PECHINOT, A ; BUISSON, M ; DUONG, M ; NEUWIRTH, C ; KAZMIERCZAK, A ; PORTIER, H</creatorcontrib><description>Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/aac.40.9.2062</identifier><identifier>PMID: 8878581</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Amoxicillin - pharmacokinetics ; Amoxicillin - pharmacology ; Amoxicillin - therapeutic use ; Animals ; Anti-Bacterial Agents - pharmacokinetics ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Colony Count, Microbial ; Drug Therapy, Combination ; Drug Therapy, Combination - pharmacokinetics ; Drug Therapy, Combination - pharmacology ; Drug Therapy, Combination - therapeutic use ; Fibrin ; Fibrin - metabolism ; Fosfomycin - pharmacokinetics ; Fosfomycin - pharmacology ; Fosfomycin - therapeutic use ; Half-Life ; Humans ; Medical sciences ; Penicillin Resistance ; Penicillins - pharmacokinetics ; Penicillins - pharmacology ; Penicillins - therapeutic use ; Pharmacology. Drug treatments ; Pneumococcal Infections ; Pneumococcal Infections - drug therapy ; Pneumococcal Infections - microbiology ; Rabbits ; Research Support, Non-U.S. Gov't ; Streptococcus pneumoniae ; Streptococcus pneumoniae - drug effects</subject><ispartof>Antimicrobial Agents and Chemotherapy, 1996-09, Vol.40 (9), p.2062-2066</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a526t-758261c34637f9141a0f8e52e00f3c0c2db7972ea76a2a15123f159a366d3e353</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC163473/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC163473/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,725,778,782,883,27913,27914,53780,53782</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3207707$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8878581$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CHAVANET, P</creatorcontrib><creatorcontrib>PEYRARD, N</creatorcontrib><creatorcontrib>PECHINOT, A</creatorcontrib><creatorcontrib>BUISSON, M</creatorcontrib><creatorcontrib>DUONG, M</creatorcontrib><creatorcontrib>NEUWIRTH, C</creatorcontrib><creatorcontrib>KAZMIERCZAK, A</creatorcontrib><creatorcontrib>PORTIER, H</creatorcontrib><title>In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Amoxicillin - pharmacokinetics</subject><subject>Amoxicillin - pharmacology</subject><subject>Amoxicillin - therapeutic use</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacokinetics</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Colony Count, Microbial</subject><subject>Drug Therapy, Combination</subject><subject>Drug Therapy, Combination - pharmacokinetics</subject><subject>Drug Therapy, Combination - pharmacology</subject><subject>Drug Therapy, Combination - therapeutic use</subject><subject>Fibrin</subject><subject>Fibrin - metabolism</subject><subject>Fosfomycin - pharmacokinetics</subject><subject>Fosfomycin - pharmacology</subject><subject>Fosfomycin - therapeutic use</subject><subject>Half-Life</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Penicillin Resistance</subject><subject>Penicillins - pharmacokinetics</subject><subject>Penicillins - pharmacology</subject><subject>Penicillins - therapeutic use</subject><subject>Pharmacology. Drug treatments</subject><subject>Pneumococcal Infections</subject><subject>Pneumococcal Infections - drug therapy</subject><subject>Pneumococcal Infections - microbiology</subject><subject>Rabbits</subject><subject>Research Support, Non-U.S. Gov't</subject><subject>Streptococcus pneumoniae</subject><subject>Streptococcus pneumoniae - drug effects</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkkuLFDEUhQtRxnF06VKIIC6EavOoJJWFi6bxMTDgQl2H26lkOkNVUiapHvsP-TutpppmXIgQCJfz3XPzOFX1kuAVIbR9D2BWDV6pFcWCPqouCVZtLbgSj6tLjIWomxY3T6tnOd_hueYKX1QXbStb3pLL6vd1QHu_jwhM8XtfDghCh8YdpAFM7A4BBm8yig7BEH954_veBzQvE4etD1B8DOjelx1yMbs4HMwiO79NR6qPJc-1s6bYbgF3_nbXH9Bow8muTjb7XCAU9K0kO5ZoojFTRmOw0xCDB_u8euKgz_bFab-qfnz6-H3zpb75-vl6s76pgVNRaslbKohhjWDSKdIQwK61nFqMHTPY0G4rlaQWpAAKhBPKHOEKmBAds4yzq-rD4jtO28F2xoaSoNdj8gOkg47g9d9K8Dt9G_eaCNZINve_PfWn-HOyuejBZ2P7HoKNU9aybbiiTP0XJFwo2ah2BusFNCnmnKw7H4ZgfQyAXq83usFa6WMAZv7dwkMeqL6LUwrzg_0TfvXwumfrUzxm_c1Jh2ygdwmC8fmMMYqlxHLGXi_Y8WvvfbJ6Hq7nYD4Y9QdfqtYI</recordid><startdate>19960901</startdate><enddate>19960901</enddate><creator>CHAVANET, P</creator><creator>PEYRARD, N</creator><creator>PECHINOT, A</creator><creator>BUISSON, M</creator><creator>DUONG, M</creator><creator>NEUWIRTH, C</creator><creator>KAZMIERCZAK, A</creator><creator>PORTIER, H</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19960901</creationdate><title>In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae</title><author>CHAVANET, P ; PEYRARD, N ; PECHINOT, A ; BUISSON, M ; DUONG, M ; NEUWIRTH, C ; KAZMIERCZAK, A ; PORTIER, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a526t-758261c34637f9141a0f8e52e00f3c0c2db7972ea76a2a15123f159a366d3e353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Amoxicillin - pharmacokinetics</topic><topic>Amoxicillin - pharmacology</topic><topic>Amoxicillin - therapeutic use</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacokinetics</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Colony Count, Microbial</topic><topic>Drug Therapy, Combination</topic><topic>Drug Therapy, Combination - pharmacokinetics</topic><topic>Drug Therapy, Combination - pharmacology</topic><topic>Drug Therapy, Combination - therapeutic use</topic><topic>Fibrin</topic><topic>Fibrin - metabolism</topic><topic>Fosfomycin - pharmacokinetics</topic><topic>Fosfomycin - pharmacology</topic><topic>Fosfomycin - therapeutic use</topic><topic>Half-Life</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Penicillin Resistance</topic><topic>Penicillins - pharmacokinetics</topic><topic>Penicillins - pharmacology</topic><topic>Penicillins - therapeutic use</topic><topic>Pharmacology. Drug treatments</topic><topic>Pneumococcal Infections</topic><topic>Pneumococcal Infections - drug therapy</topic><topic>Pneumococcal Infections - microbiology</topic><topic>Rabbits</topic><topic>Research Support, Non-U.S. Gov't</topic><topic>Streptococcus pneumoniae</topic><topic>Streptococcus pneumoniae - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CHAVANET, P</creatorcontrib><creatorcontrib>PEYRARD, N</creatorcontrib><creatorcontrib>PECHINOT, A</creatorcontrib><creatorcontrib>BUISSON, M</creatorcontrib><creatorcontrib>DUONG, M</creatorcontrib><creatorcontrib>NEUWIRTH, C</creatorcontrib><creatorcontrib>KAZMIERCZAK, A</creatorcontrib><creatorcontrib>PORTIER, H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CHAVANET, P</au><au>PEYRARD, N</au><au>PECHINOT, A</au><au>BUISSON, M</au><au>DUONG, M</au><au>NEUWIRTH, C</au><au>KAZMIERCZAK, A</au><au>PORTIER, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>1996-09-01</date><risdate>1996</risdate><volume>40</volume><issue>9</issue><spage>2062</spage><epage>2066</epage><pages>2062-2066</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>8878581</pmid><doi>10.1128/aac.40.9.2062</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0066-4804 |
ispartof | Antimicrobial Agents and Chemotherapy, 1996-09, Vol.40 (9), p.2062-2066 |
issn | 0066-4804 1098-6596 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_163473 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Amoxicillin - pharmacokinetics Amoxicillin - pharmacology Amoxicillin - therapeutic use Animals Anti-Bacterial Agents - pharmacokinetics Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Colony Count, Microbial Drug Therapy, Combination Drug Therapy, Combination - pharmacokinetics Drug Therapy, Combination - pharmacology Drug Therapy, Combination - therapeutic use Fibrin Fibrin - metabolism Fosfomycin - pharmacokinetics Fosfomycin - pharmacology Fosfomycin - therapeutic use Half-Life Humans Medical sciences Penicillin Resistance Penicillins - pharmacokinetics Penicillins - pharmacology Penicillins - therapeutic use Pharmacology. Drug treatments Pneumococcal Infections Pneumococcal Infections - drug therapy Pneumococcal Infections - microbiology Rabbits Research Support, Non-U.S. Gov't Streptococcus pneumoniae Streptococcus pneumoniae - drug effects |
title | In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T08%3A10%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vivo%20activity%20and%20pharmacodynamics%20of%20amoxicillin%20in%20combination%20with%20fosfomycin%20in%20fibrin%20clots%20infected%20with%20highly%20penicillin-resistant%20Streptococcus%20pneumoniae&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=CHAVANET,%20P&rft.date=1996-09-01&rft.volume=40&rft.issue=9&rft.spage=2062&rft.epage=2066&rft.pages=2062-2066&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/aac.40.9.2062&rft_dat=%3Cproquest_pubme%3E15697498%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15697498&rft_id=info:pmid/8878581&rfr_iscdi=true |